The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.

OA: closed
AI-generated deep summary by qwen3.7-flash, 2026-08-25 · read from full text

The provided text consists of website navigation elements and error messages rather than the actual content of a research article. It indicates that the specific paper titled "The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers" could not be located or accessed on the journal's platform. Consequently, no scientific findings, methodologies, or results can be summarized from this input. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The aryl hydrocarbon receptor repressor (AHRR) is a bHLH/Per-ARNT-Sim transcription factor located in a region of chromosome 5 (5p15.3) that has been proposed to contain one or more tumor suppressor genes. We report here consistent downregulation of AHRR mRNA in human malignant tissue from different anatomical origins, including colon, breast, lung, stomach, cervix, and ovary, and demonstrate DNA hypermethylation as the regulatory mechanism of AHRR gene silencing. Knockdown of AHRR gene expression in a human lung cancer cell line using siRNA significantly enhanced in vitro anchorage-dependent and -independent cell growth as well as cell growth after transplantation into immunocompromised mice. In addition, knockdown of AHRR in non-clonable normal human mammary epithelial cells enabled them to grow in an anchorage-independent manner. Further, downregulation of AHRR expression in the human lung cancer cell line conferred resistance to apoptotic signals and enhanced motility and invasion in vitro and angiogenic potential in vivo. Ectopic expression of AHRR in tumor cells resulted in diminished anchorage-dependent and -independent cell growth and reduced angiogenic potential. These results therefore demonstrate that AHRR is a putative new tumor suppressor gene in multiple types of human cancers.
Full text 670 characters · extracted from oa-doi-fallback · click to expand
You don't have javascript enabled. Please enable javascript for full site funcionality. Go to The Journal of Clinical Investigation About Editors Consulting Editors For authors Journal stats Publication ethics Publication alerts by email Transfers Advertising Job board Contact Physician-Scientist Development Current issue Past issues By specialty COVID-19 Cardiology Immunology Metabolism Nephrology Oncology Pulmonology All ... Videos Collections In-Press Preview Resource and Technical Advances Clinical Research and Public Health Research Letters Editorials Perspectives Physician-Scientist Development Reviews Top read articles Unable to find article Advertisement

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-06T09:34:12.023084+00:00